Cagrilintide (10 mg Vial)

Read the Cagrilintide Research Guide. Review the research context and evidence limitations.

Cagrilintide (10 mg Vial) is supplied for controlled laboratory evaluation of Cagrilintide within Weight Loss / Metabolic Research studies.

• Research material: Cagrilintide
• Listed strength and format: 10 mg Vial
• Research category: Weight Loss / Metabolic Research

Cagrilintide and amylin receptor research

Cagrilintide, also called AM833 in the literature, is a lipidated amylin analogue. A 2021 receptor-pharmacology study compared its binding, activation and regulation across amylin and calcitonin receptor systems. These are useful distinctions when reviewing metabolic-signaling research; this listing is for Cagrilintide alone, not a combination with Semaglutide.

Read Fletcher et al. (2021), the AM833 receptor comparison study. The publication describes the tested experimental material and does not certify the contents or quality of this SRP vial.

What the 10 mg listing means

The listed amount is total peptide content per vial, not a prepared solution concentration. Before ordering, review the available batch documentation and confirm that it matches the lot you need. Ask SRP about current-lot documentation if a report or specification needs clarification.

For laboratory research only. Not for human or animal use, consumption, administration, diagnosis, treatment, or therapeutic application.